InvestorPlace - Stock Market News, Stock Advice & Trading Tips
The fate of Crispr and CRSP stock will be determined by the success of other drugs in the company's pipeline rather than Casgevy.
The post CRSP Stock Alert: CRISPR Therapeutics Is Losing Its Medical Chief appeared first on InvestorPlace.
More From InvestorPlace